A prominent prostate cancer researcher has been sued by a biotech company for allegedly making false claims about a biomarker for detecting prostate cancer, according to a startling story in yesterday's Pittsburgh Tribune-Review.
The article says that in 2001, Robert Getzenberg, then of the University of Pittsburgh claimed to find a prostate cancer biomarker called EPCA-2 that his university patented. This lead to the formation of a company, Onconome Inc., to develop and market it. Getzberg became a consultant to the company. But now Onconome, based in Redmond, Washington, is suing Getzenberg in federal court for presenting scientific results over 6 years that "were and are imaginary," the lawsuit reportedly states. Getzenberg is now at Johns Hopkins University in Baltimore, Maryland.